Neoplastic cells exhibit higher oxidative stress compared to normal cells; however, antioxidants based clinical trials have mostly failed. Another attractive therapeutic approach is to further increase the oxidative stress in cancer cells leading to cell death.Herein, we show that Procyanidin B2 3,3″-di-O-gallate (B2G2), the most active constituent of grape seed extract, treatment causes cell death in human prostate cancer (PCa) cells (LNCaP and 22Rv1) via increasing the reactive oxygen species (ROS) generation. Mechanistically, B2G2 treatment decreased the mitochondrial electron transport chain complex III activity leading to enhanced mitochondrial superoxide generation and decreased ATP production in LNCaP cells. Additional molecular studies revealed that B2G2-induced cell death was mediated mainly through ROS-induced sustained activation of ERK1/2, which was due to inhibition of MAP kinase phosphatase (MKP) activity as over-expression of MKP3 in LNCaP cells conferred significant protection against B2G2-induced cell death. Along with ERK1/2, AMPactivated protein kinase α (AMPKα) was also activated by B2G2 treatment, and pretreatment with AMPKα inhibitor compound C significantly reversed the cytotoxic effects of B2G2 in LNCaP cells. Furthermore, pre-treatment of MKP3 over-expressing LNCaP cells with compound C further reduced the B2G2-induced cell death, suggesting the involvement of AMPKα along with MKP3 and ERK1/2 in the biological effects of B2G2. Together, these results for the first time identified that oxidative stress and MKP3 inhibition play a critical role in B2G2-induced cell death in PCa cells through sustained activation of both ERK1/2 and AMPKα. These results offer a unique opportunity to control this deadly malignancy through B2G2 use.AMP-activated kinase, dual-specificity phosphoprotein phosphatase, extracellular-signalregulated kinase, oxidative stress, procyanidin B2 3,3″-di-O-gallate, prostate cancer Abbreviations: ADT, androgen deprivation therapy; AMPKα, adenosine monophosphate-activated protein kinase alpha; ANOVA, analysis of variance; ATP, adenosine triphosphate; B2G2, procyanidin B2 3,3″-di-O-gallate; CRPC, castration-resistant prostate cancer; DCFDA, 2′,7′-dichlorofluorescein diacetate; ERK1/2, extracellular signal-regulated kinase 1/2; GSE, grape seed extract; MKP, MAP kinase phosphatase; NAC, N-acetyl-L-cysteine; PCa, prostate cancer; ROS, reactive oxygen species; SEM, standard error of mean. ROS, generated inside the cells as by-product of normal metabolism, could cause tissue injury and DNA damage but in normal cells, a dynamic balance is maintained between ROS level (pro-oxidant) and antioxidant proteins and enzymes. However, with the age this balance shifts toward pro-oxidant resulting in a chronic increase in ROS.
7-9Based upon these observations, in the past, several studies have focused on using anti-oxidants for both preventive and therapeutic approaches in the management of PCa. however, these clinical trials failed to establish any relationship between overall PCa risk and d...